Amgen Inc. buy Piper Jaffray Companies
Start price
02.01.25
/
50%
€254.50
Target price
02.01.26
€300.51
Performance (%)
8.92%
End price
03.01.26
€277.20
Summary
This prediction ended on 03.01.26 with a price of €277.20. With a performance of 8.92%, the BUY prediction by Piper_Jaffray_Compan for Amgen Inc. closed with a slight gain. Dividends of €9.41 are taken into consideration when calculating the performance. Piper_Jaffray_Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -0.154% | -0.154% | 9.440% |
| iShares Core DAX® | -3.986% | -2.814% | 4.157% |
| iShares Nasdaq 100 | 0.345% | -0.748% | 9.471% |
| iShares Nikkei 225® | -3.853% | 4.229% | 28.358% |
| iShares S&P 500 | 0.298% | 0.379% | 6.139% |
Comments by Piper_Jaffray_Compan for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "overweight" rating re-affirmed by analysts at Piper Sandler Companies. They now have a $310.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Piper_Jaffray_Compan gewählte maximale Laufzeit wurde überschritten